Author(s): Paterson DL, Hujer KM, Hujer AM, Yeiser B, Bonomo MD, et al.
A huge variety of extended-spectrum β-lactamases (ESBLs) have been detected during the last 20 years. The majority of these have been of the TEM or SHV lineage. We have assessed ESBLs occurring among a collection of 455 bloodstream isolates of Klebsiella pneumoniae, collected from 12 hospitals in seven countries. Multiple β-lactamases were produced by isolates with phenotypic evidence of ESBL production (mean of 2.7 β-lactamases per isolate; range, 1 to 5). SHV-type ESBLs were the most common ESBL, occurring in 67.1% (49 of 73) of isolates with phenotypic evidence of ESBL production. In contrast, TEM-type ESBLs (TEM-10 type, -12 type, -26 type, and -63 type) were found in just 16.4% (12 of 73) of isolates. The finding of TEM-10 type and TEM-12 type represents the first detection of a TEM-type ESBL in South America. PER (for Pseudomonas extended resistance)-type β-lactamases were detected in five of the nine isolates from Turkey and were found with SHV-2-type and SHV-5-type ESBLs in two of the isolates. CTX-M-type ESBLs (blaCTX-M-2 type and blaCTX-M-3 type) were found in 23.3% (17 of 73) of isolates and were found in all study countries except for the United States. We also detected CTX-M-type ESBLs in four countries where they have previously not been described—Australia, Belgium, Turkey, and South Africa. The widespread emergence and proliferation of CTX-M-type ESBLs is particularly noteworthy and may have important implications for clinical microbiology laboratories and for physicians treating patients with serious K. pneumoniae infections.
Referred From: http://aac.asm.org/content/47/11/3554.long
Author(s): Queenan AM, Bush K
Author(s): Doumith M, Ellington MJ, Livermore DM, Woodford N
Author(s): Walsh TR
Author(s): Bradford PA
Author(s): Sidjabat HE, Silveira FP, Potoski BA, Abu-Elmagd KM, Adams- Haduch JM, et al.
Author(s): Patel G, Bonomo RA
Author(s): Fallah F, Hakemi Vala M, Hashemi A, Shams S
Author(s): Nordmann P, Naas T, Poirel L
Author(s): Haji Hashemi B, Farzanehkhah M, Dolatyar A, Imani M, Farzami MR, et al.
Author(s): Center for disease control and Prevention
Author(s): Patzer JA, Dzierzanowska D
Author(s): Lee K, Yong D, Yum JH, Lim YS, Bolmstrom A, et al.
Author(s): Boyd DA, Tyler S, Christianson S, McGeer A, Muller MP, et al.
Author(s): Monstein HJ, Östholm-Balkhed A, Nilsson MV, Nilsson M, Dornbusch K, et al.